Moreover, emerging biomarkers such as copeptin, CXCL9, angiopoietin-2, and vitamin D have been investigated for their role in endothelial dysfunction, immune dysregulation, and clinical severity [8,9,10,11]. Here, CXCL9 is linked to endothelial dysfunction.